Potential benefits of ticagrelor plus aspirin in Chinese patients with stable coronary artery disease and diabetes

被引：0
|
作者：
Sun, W. [1 ]
Yan, B. [1 ]
机构：
[1] Chinese Univ Hong Kong, Hong Kong, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1218 / 1218
页数：1
相关论文
共 50 条
  • [31] There may be a role for addition of rivaroxaban to aspirin in patients with stable coronary artery disease
    Banerjee, Amitava
    BMJ EVIDENCE-BASED MEDICINE, 2019, 24 (02) : 78 - 79
  • [32] TICAGRELOR VERSUS CLOPIDOGREL IN AFRICAN AMERICAN PATIENTS WITH CORONARY ARTERY DISEASE AND DIABETES MELLITUS
    Waksman, Ron
    Maya, Juan
    Angiolillo, Dominick
    Carlson, Glenn
    Teng, Renli
    Caplan, Richard
    Ferdinand, Keith
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A211 - A211
  • [33] Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease
    Larsen, Sanne Bojet
    Grove, Erik Lerkevang
    Neergaard-Petersen, Sos
    Wurtz, Morten
    Hvas, Anne-Mette
    Kristensen, Steen Dalby
    PLOS ONE, 2015, 10 (05):
  • [34] Ticagrelor and Infection Risk in Patients with Coronary Artery Disease
    Vicent, Lourdes
    Bruna, Vanesa
    Devesa, Carolina
    Sousa-Casasnovas, Iago
    Juarez, Miriam
    Alcala, Luis
    Munoz, Patricia
    Fernandez-Aviles, Francisco
    Martinez-Selles, Manuel
    CARDIOLOGY, 2021, 146 (06) : 698 - 704
  • [35] Antiplatelet Effects of Ticagrelor versus Clopidogrel in Native American Patients With Stable Coronary Artery Disease
    DeRaad, Roger
    Jennings, Lisa K.
    Hord, Edward
    Welder, James S.
    CIRCULATION, 2015, 132
  • [36] Ticagrelor in patients with symptomatic peripheral artery disease and prior coronary artery disease
    Berger, J.
    Heizer, G.
    Baumgartner, I.
    Fowkes, F. G. R.
    Held, P.
    Katona, B. G.
    Norgren, L.
    Jones, W. S.
    Lopes, R. D.
    Abramson, B. L.
    Millegard, M.
    Blomster, J.
    Hiatt, W. R.
    Patel, M. R.
    Mahaffey, K. W.
    EUROPEAN HEART JOURNAL, 2017, 38 : 452 - 452
  • [37] Frequency of aspirin resistance in patients with stable coronary artery disease on long-term aspirin therapy
    Postula, Marek
    Serafin, Agnieszka
    Filipiak, Krzysztof
    Tarchalska, Bozena
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 : S234 - S235
  • [38] Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
    Xi, Ziwei
    Li, Jianan
    Qiu, Hong
    Guo, Tingting
    Wang, Yong
    Li, Yang
    Zheng, Jianfeng
    Dou, Kefei
    Xu, Bo
    Wu, Yongjian
    Qiao, Shubin
    Yang, Weixian
    Yang, Yuejin
    Gao, Runlin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [39] Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes
    Faouzi Addad
    Tahar Chakroun
    Ismail Elalamy
    Fatma Abderazek
    Saoussen Chouchene
    Zohra Dridi
    Gregoris T. Gerotziafas
    Mohamed Hatmi
    Mohsen Hassine
    Habib Gamra
    International Journal of Hematology, 2010, 92 : 296 - 301
  • [40] Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes
    Addad, Faouzi
    Chakroun, Tahar
    Elalamy, Ismail
    Abderazek, Fatma
    Chouchene, Saoussen
    Dridi, Zohra
    Gerotziafas, Gregoris T.
    Hatmi, Mohamed
    Hassine, Mohsen
    Gamra, Habib
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (02) : 296 - 301
12345